Johnson & Johnson Articles
Angiotech joined by Chris Dennis as senior VP
9 April 2007
Basilea to raise funds through share offer
26 March 2007
FDA extends Levaquin marketing exclusivity
26 March 2007
J&J subsids receive three US subpoenas
19 March 2007
BioFocus DPI and Janssen in supply deal
19 March 2007
EC clears new Remicade dosing for use in RA
12 March 2007
Waxman investigates marketing practices
12 March 2007
Remicade pricing is subject of US subpoena
12 March 2007
Ortho Biotech reviews ESA Rxing info with FDA
5 March 2007
J&J unit launches movie documentary, slashes DTC ads
26 February 2007
Tibotec's Prezista cleared for HIV in EU
26 February 2007
Improper payments by unnamed J&J unit
19 February 2007
Qiagen expands real-time PCR licenses
19 February 2007
Centocor's CNTO 1275 impresses in psoriasis study
19 February 2007
Alkermes reports $3M 4th-qtr 2006 net income
19 February 2007
Remicade of benefit in treatment of psoriasis
12 February 2007
Stock Commentary - New York week to Jan 29, 2007
5 February 2007
Ortho-McNeil extends Cellzome accord by one year
5 February 2007
Japan stock market week to Jan 29, 2007
5 February 2007
Grunenthal extends Ortho tapentadol license
5 February 2007
J&J's 4th qtr 2006 EPS beats analysts' estimate
29 January 2007
Boston Sci's Taxus favorable TLR rate vs J&J's Cypher
22 January 2007
Vernalis recruits Jean Hubble for US post
22 January 2007
Market research is critical to reveal a brands' potential
22 January 2007
Kinaxo to perform analysis for J&J R&D
22 January 2007
Basilea's ceftobiprole meets Ph II endpoint
22 January 2007
Kinaxo to perform analysis for J&J R&D
22 January 2007
Basilea's ceftobiprole meets Ph II endpoint
22 January 2007
AMDL to produce levofloxacin in China
15 January 2007
Patent expiry will "constrain" antibacterial market
15 January 2007
Millipore in kinase screening deal with J&J
15 January 2007
Headlines 25 years ago this week....
15 January 2007
Pfizer completes sale of consumer health care business
22 December 2006
Study finds role for J&J anemia drug in cancer
18 December 2006
FDA waives COI rules for stent panel
18 December 2006
Lilly maintains cost-effectiveness of Zyprexa
11 December 2006
Pfizer increases 2006 earnings forecast
11 December 2006
Plethora signs PSD401 clinical trial supply deal
4 December 2006
Bi-monthly Procrit effective in CKD anemia
27 November 2006
J&J to boost Cordis unit with Conor Med
27 November 2006
US drugmakers lose price-fixing ruling
13 November 2006
J&J's Concerta "less potential for abuse"
6 November 2006
S*BIO Pte names Joy Zhu senior VP, global clinical development
6 November 2006
Zeltia's 9-month net income rises 10%
6 November 2006
Millenium/Ortho Biotech to market Velcade in US
6 November 2006
Study: Procrit cheaper than rival anemia drugs
6 November 2006
US court denies Roche's motion to dismiss Amgen's law suit
30 October 2006
NAA urges caution of Risperdal's side effects
30 October 2006
Best practices for M&A integration
23 October 2006
Counterfeit test strips found in USA
23 October 2006
Genzyme Japan appoints general manager
23 October 2006
J&Js 3rd-qtr profit rises 8.7% to $2.76B
23 October 2006
Boeh Ing buys J&J/Pfizer's OTC Zantac
23 October 2006
NICE rules out dementia drugs for mild AD
16 October 2006
FDA approves Risperdal for autistic irritability
16 October 2006
IDMC recommends Ph III Yondelis trial continues
16 October 2006
Wyeth's Tygacil comparable to J&J's Levaquin
9 October 2006
J&J schizophrenia drug gets approvable letter
9 October 2006
Headlines 25 years ago this week....
25 September 2006
Bayer/J&J and BI atrial fibrillation drugs "have blockbuster potential"
18 September 2006
Appeals court rules for Mylan on oxybutynin
18 September 2006
Headlines 25 years ago this week....
11 September 2006
Appointments at Centocor and J&J
4 September 2006
Japan stock market week to Aug 28, 2006
4 September 2006
CORRECTION: IAS HIV treatment guidelines
4 September 2006
Peakadilly closes financing at 14.5 million euros
28 August 2006
Epigenomics and J&J sign cancer R&D accord
14 August 2006
PharmaMar's Yondelis filed with EMEA
7 August 2006
Pfizer
31 July 2006
J&J's record 2nd-qtr 2006 sales boost profit 10%
24 July 2006
Abbott's 2nd qtr profit drops on Guidant buy
24 July 2006
Paliperidone effective in schizophrenia
24 July 2006
J&J's Cordis buys Ensure Medical, gains ACD
24 July 2006
UK's NICE appeal, consultation deadline
3 July 2006
Stock Commentary - New York week toJune 26, 2006
3 July 2006
Japan stock market week to June 26, 2006
3 July 2006
Tibotec's darunavir approved in USA
3 July 2006
Cordis' new stent approved for use in Europe
3 July 2006
J&J wins bidding war for Pfizer
3 July 2006
Stock Commentary - New York week toJune 12, 2006
19 June 2006
Yondelis filing preparation continues
12 June 2006
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
